osteoarthritis

MEDIPOST Clears Product Approval Renewal of CARTISTEM by the Ministry of Food and Drug Safety(MFDS)

MEDIPOST signs a joint research agreement with LG Chemical

MEDIPOST, signs a contract with SK Bioland for an ankle joint indication

MEDIPOST acquires the patent in Mexico for ‘CARTISTEM’

Significant increase in the revenue of MEDIPOST stem cell therapeutics CARTISTEM in comparison to the previous year

MEDIPOST’s Stem Cell Technology Covered in Depth by Taiwanese News Channel FTV

MEDIPOST Obtains Patent for its ‘CARTISTEM’ Production Technology’ in Six European Countries

MEDIPOST Begins Sales of its Stem Cell Drug, ‘CARTISTEM’

Chinese Securities Company Praises MEDIPOST as a “Company with Most Profitable Stem Cell Drug”

MEDIPOST’s Stem Cell Drug ‘CARTISTEM’ Hits 5,000 Sales Mark

MEDIPOST Obtains Patent in US for its Arthritis Treatment Technique

Singapore/Taiwan consecutively invited MEDIPOST to its stem cell forums